6505--Diltiazem SA Capsules (AB3)
Veterans Affairs · NAC PHARMACEUTICALS (36E797)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36E79726R0022 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0022 for an unrestricted procurement for Diltiazem 24Hr Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract p… (show all)
eriod will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79726R0022 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 15, 2026, with a tentative closing date of June 1, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 DILTIAZEM (EQV-CARDIZEM AB3) 120MG 24HR CAP 90 45,597 2 DILTIAZEM (EQV-CARDIZEM AB3) 180MG 24HR CAP 90 38,296 3 DILTIAZEM (EQV-CARDIZEM AB3) 240MG 24HR CAP 90 33,861 4 DILTIAZEM (EQV-CARDIZEM AB3) 300MG 24HR CAP 90 5,982 5 DILTIAZEM (EQV-CARDIZEM AB3) 360MG 24HR CAP 90 6,769
Who won similar work
77 award notices on SAM.gov in the last 24 months. Matched by: Same office (NAC PHARMACEUTICALS (36E797)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (77): middle half $4.8M to $26.6M, median $11.7M; range $114K to $465.4M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 24 | $305.9M | Sep 15, 2026 |
| EXELAN PHARMACEUTICALS INC | 7 | $209.8M | Mar 5, 2026 |
| XLCARE PHARMACEUTICALS INC | 6 | $144.4M | Mar 9, 2026 |
| AVKARE LLC | 6 | $134.0M | Jul 22, 2026 |
| RADHA PHARMACEUTICALS INC | 6 | $69.3M | Apr 17, 2026 |
| PFIZER INC · $PFE · $59.6B | 2 | $120.9M | Apr 29, 2025 |
| SEQIRUS USA INC | 2 | $82.6M | Dec 15, 2025 |
| DR REDDY'S LABORATORIES, INC. · $RDY | 2 | $38.9M | Jan 9, 2026 |
| SOLCO HEALTHCARE US LLC | 2 | $21.5M | Jun 18, 2026 |
| MARLEX PHARMACEUTICALS INC | 2 | $10.3M | May 22, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $PFE reported $59.6B revenue in FY2025. The median single-winner award in these 77 past awards, $11.7M, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 15, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$26.6M6505--Mesalamine 1200mg Tablet (VA-27-00000768)No listed company matched (Materiality N/A)
- Aug 19, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$9.6M6505--Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027No listed company matched (Materiality N/A)
- Jul 24, 2026MYLAN PHARMACEUTICALS INC$436.5M6505--Budesonide/Formoterol INHNo listed company matched (Materiality N/A)
- Jul 22, 2026AVKARE LLC$1.9M6505--Famciclovir TabletsNo listed company matched (Materiality N/A)
- Jul 22, 2026ANIP ACQUISITION CO BAUDETTE 56623$3.7M6505--Benazepril HCL TabletsNo listed company matched (Materiality N/A)
- Jun 25, 2026PURACAP LABORATORIES LLC$32.4M6505--PuraCap Contract Award Venlafaxine 24HR SA CapsulesNo listed company matched (Materiality N/A)
- Jun 18, 2026SOLCO HEALTHCARE US LLC$8.6M6505--Ropinirole HCL Tablets 9/28/2026 - 9/27/2027No listed company matched (Materiality N/A)
- May 22, 2026MARLEX PHARMACEUTICALS INC$5.9M6505--Melatonin Tablets Effective 09/15/26 - 09/14/27No listed company matched (Materiality N/A)
- May 19, 2026AVKARE LLC$2.0M6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027No listed company matched (Materiality N/A)
- May 7, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$21.0M6505--Buprenorphine AwardNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $61K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 3 insider buys and 1 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.